Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;15(4):333-340.
doi: 10.2450/2016.0038-16. Epub 2016 Jul 25.

Platelet gel: a new therapeutic tool with great potential

Andrea Piccin  1   2   3 , Angela M Di Pierro  1   2   3   4   5 , Lucia Canzian  6 , Marco Primerano  2   3   7 , Daisy Corvetta  1   2   3   8 , Giovanni Negri  2   3   8 , Guido Mazzoleni  2   3   8 , Günther Gastl  5 , Michael Steurer  5 , Ivo Gentilini  6 , Klaus Eisendle  2   3   9 , Fabrizio Fontanella  2   3   10
Affiliations
Review

Platelet gel: a new therapeutic tool with great potential

Andrea Piccin et al. Blood Transfus. 2017 Jul.

Abstract

Chronic wounds, such as diabetic foot ulcers, represent a serious clinical problem for patients and clinicians. Management of these wounds has a strong economic impact worldwide. Complications resulting from injuries are a frequent cause of morbidity and mortality. Chronic wounds lead to infections, painful dressings and prolonged hospitalisation. This results in poor patient Quality of Life and in high healthcare costs. Platelet concentrates (PC) are defined as autologous or allogeneic platelet derivatives with a platelet concentration higher than baseline. PC are widely used in different areas of Regenerative Medicine in order to enhance wound healing processes; they include platelet-rich plasma (PRP), platelet gel (PG), platelet-rich fibrin (PRF), serum eye drops (E-S), and PRP eye drops (E-PRP). This review highlights the use of platelet-rich plasma (PRP) and platelet gel (PG) preparation for clinical use.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Role of platelet-derived growth factor (PDGF) in wound healing processes. PLT: platelet; EGF: epidermal growth factor; PDGF: platelet-derived growth factor; VEGF: vascular-endothelial growth factor; CTGF: connective tissue growth factor; TGF-β: transforming growth factor-β; FGF: fibroblast growth factor.
Figure 2
Figure 2
Functional roles of platelets (PLT).
Figure 3
Figure 3
Flow-chart in platelet-rich plasma (PRP) preparation. PPP: platelet-poor plasma; RBC: red blood cell.
See this image and copyright information in PMC

References

    1. Alonso JE, Lee J, Burgess AR, et al. The management of complex orthopedic injuries. Surg Clin North Am. 1996;76:879–903. - PubMed
    1. Bischoff M, Kinzl L, Schmelz A. [The complicated wound]. Unfallchirurg. 1999;102:797–804. [In German.] - PubMed
    1. Picard F, Hersant B, Bosc R, et al. Should we use platelet-rich plasma as an adjunct therapy to treat “acute wounds”, “burns” and “laser therapies”: A review and a proposal of a quality criteria checklist for further studies. Wound Repair Regen. 2015;23:163–70. - PubMed
    1. Brem H, Young J, Tomic-Canic M, et al. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg Technol Int. 2003;11:23–31. - PubMed
    1. Reiber GE, Boyko EJ, Smith DG. Lower Extremity Foot Ulcers and Amputations in Diabetes. In: Harris MI, Stern MP, editors. Diabetes in America. Bethesda, MD: U.S. Government Printing Office; 1995. pp. 409–28.